1-2 of 2
Hao Hu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Increased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic Patients

Open Access
Hao Hu, Wenjun Sun, Shuqin Yu, Xiafei Hong, Weiyun Qian, Bingqian Tang, Dong Wang, Ling Yang, Jifang Wang, Caoming Mao, Libin Zhou, Guoyue Yuan
Journal: Diabetes Care
Diabetes Care 2014;37(10):2718–2722
https://doi.org/10.2337/dc14-0602
Published: 10 September 2014
View articletitled, Increased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic Patients
Open the PDF for Increased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic Patients in another window
Includes: Supplementary data
Journal Articles

DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks

Open Access
John B. Buse, MD, PHD, Daniel J. Drucker, MD, Kristin L. Taylor, PHD, Terri Kim, MS, Brandon Walsh, PHD, Hao Hu, MS, Ken Wilhelm, MD, Michael Trautmann, MD, Larry Z. Shen, PHD, Lisa E. Porter, MD, for the DURATION-1 Study Group
Journal: Diabetes Care
Diabetes Care 2010;33(6):1255–1261
https://doi.org/10.2337/dc09-1914
Published: 09 March 2010
View articletitled, DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks
Open the PDF for DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks in another window
Includes: Supplementary data